MedNextz.com

Recognized for excellence in veterinary telemedicine and customer service.

  • Golden Hour awarded Veterinary Telemedicine Service of the Year
  • Wins dual Stevie Awards
  • Recognized for customer service excellence

Golden Hour has been awarded the title of Veterinary Telemedicine Service of the Year at the 2026 Stevie Awards, highlighting its significant impact in the field of veterinary telemedicine. This recognition underscores the service's commitment to providing accessible and high-quality care for pets through innovative telehealth solutions. The award also reflects Golden Hour's dedication to enhancing customer experiences and support for veterinary professionals.

The Stevie Awards celebrate organizations across various sectors, with a focus on recognizing excellence in customer service and innovation. Golden Hour's dual win further emphasizes its achievements in providing top-tier veterinary care remotely. This accolade positions the company as a leader in the telemedicine space, encouraging advancements in veterinary services and patient care.

The recognition from the Stevie Awards serves as a testament to Golden Hour's ongoing efforts to improve veterinary access and efficiency. With the growing trend in veterinary telemedicine, the company remains focused on enhancing its platform and services to meet the needs of pet owners and veterinarians alike. As veterinary telemedicine continues to evolve, awards like these highlight the importance of customer-centric approaches in the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…